Skip to main content

Table 2 Features and distribution of treatment modalities

From: Long-term functional outcome after laryngeal cancer treatment

Treatment Parameters Primary Treatment Modality
Surgery (Chemo)Radiotherapy
n = 118 (24.7%) n = 359 (75.3%)
Transoral laser microsurgery 62 (52.5%)  
Partial open laryngectomy 17 (14.4%)  
Total laryngectomy 39 (33.1%)  
Neck Dissection 62 (52.5%) 25 (7%)a
Adjuvant treatment 69 (58.5%)  
Radiotherapy technique
 conventional 2-dimensional 8 (11.6%) 9 (2.5%)
 conventional 3-dimensional 47 (68.1%) 230 (64.1%)
 static field intensity modulated 10 (14.5%) 48 (13.4%)
 volumetric modulated arc 4 (5.8%) 72 (20.1%)
Median total dose in Gy (range) 66 (60–72) 70 (64–76)
Median duration of radiotherapy in days (range) 46 (36–59) 49 (39–71)
Induction chemotherapy 2 (1.7%) 9 (2.5%)
Concomitant systemic therapy 19 (27.5%) 92 (25.6%)
 Cisplatin 3w 15 (78.9%) 61 (66.3%)
 Carboplatin + 5-fluorouracil 3w 2 (10.5%) 7 (7.6%)
 Cetuximab weekly 2 (10.5%) 24 (26.1%)
  1. a up-front neck dissection followed by primary chemoradiotherapy, 3w Three-weekly regimen